Premature Atrial Contractions During Exercise
Premature atrial contractions (PACs) that occur during exercise are generally managed with reassurance and risk-factor and trigger evaluation. Supraventricular premature beats usually do not require antiarrhythmic therapy. [1]
Initial Assessment During Exercise-Associated Symptoms
- Exercise-associated PACs should prompt assessment for provoking factors such as electrolyte and acid-base imbalance and volume overload. [1]
- Evaluation should include determination of whether symptoms represent isolated PACs versus supraventricular tachycardia (SVT) or atrial tachyarrhythmia. [2]
Nonpharmacologic Management
- Avoidance of cardiac stimulants and correction of reversible triggers should be attempted before drug treatment. [3]
- Exercise-related symptoms should trigger reassessment for contributing conditions such as myocardial ischemia, systemic illness, or medication effects. [1]
Pharmacologic Management for Symptomatic PACs
- Beta-blockers are recommended for symptomatic supraventricular premature contractions (SVPCs) (Class IIa, Level C). [4]
- Oral verapamil or diltiazem are options for symptomatic control in supraventricular premature contraction/SVPC patients when beta-blockers are not preferred or are ineffective (Class IIa, Level C). [4]
- Antiarrhythmic drug therapy is not indicated for asymptomatic PAC/SVPC management as a routine strategy. [4]
Monotherapy Versus Combination Therapy
- Symptom-directed monotherapy with beta-blocker therapy is used as initial pharmacologic management for symptomatic SVPCs. [4]
- Non-dihydropyridine calcium channel blocker therapy (verapamil or diltiazem) is used as an alternative strategy rather than routine immediate combination therapy when beta-blockers are not appropriate. [4]
Indications for Escalation of Care
- Escalation is indicated when exercise-associated atrial ectopy is not isolated and instead represents recurrent or sustained SVT requiring rhythm or rate management. [2]
- Catheter ablation should be considered in patients with persistent or drug-refractory arrhythmia that is no longer responsive to medical therapy. [2]
Common Pitfalls to Avoid
- Treatment initiation should not be based solely on the presence of supraventricular premature beats because supraventricular premature beats usually do not require therapy. [1]
- Trigger-related causes should not be overlooked because identification and correction of triggers is a core management step for supraventricular premature beats in clinical settings. [1]
Targets of Therapy
- Treatment goals for symptomatic PAC/SVPCs are symptom reduction and decreased ectopy burden rather than elimination of PACs in all cases. [1]
- For symptomatic patients receiving rate-slowing therapy, symptom improvement rather than complete arrhythmia eradication is the clinical target. [1]
References
[1] ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. [2] ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias (executive summary). [3] ESC 2019 Guidelines for the management of patients with supraventricular tachycardia. [4] JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.